German CDMO LTS Lohmann has announced that it will acquire US-based CDMO Renaissance Lakewood, which specializes in injectables and nasal sprays. According to the announcement, Renaissance currently employs approximately 500 employees. LTS currently offers services for a variety of delivery forms and has manufacturing facilities in Germany, the US, and Israel.
According to Renaissance’s web site, the company’s Lakewood, New Jersey site was opened in 1979 and acquired by West Pharmaceutical in 1995. The facility was acquired by DPT Labs in 2001, and DPT was acquired by Renaissance in 2012. In 2023, Renaissance announced a major expansion of its nasal spray labs in Lakewood and the company opened new headquarters in 2024.
LTS CEO Bas van Buijtenen commented, “We are delighted to welcome Renaissance Lakewood to the LTS family. This acquisition marks a significant step in our strategy to expand our CDMO capabilities and strengthen our position as a global leader in innovative drug delivery solutions. Renaissance’s expertise in nasal sprays and sterile dosage forms perfectly complements our existing portfolio and will enable us to offer even greater value to our partners and patients worldwide. We look forward to working together to drive innovation and deliver high quality solutions across a broader range of therapeutic modalities.”
Renaissance President and CEO Serge Maltais said, “I am incredibly proud of what we have built at Renaissance thanks to the hard work and dedication of our employees. Now, as part of the LTS family, our combined strengths will position us even better to meet the complex needs of our clients and deliver greater value to the industry. We are excited to begin this new chapter and look forward to achieving success together.”
Read the LTS Lohmann press release
